Pay in 4 interest-free payments of $7.24 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Manufactured by Eli Lilly and Company and first approved in September 2014, Trulicity holds two distinct FDA indications: glycemic control in adults with type 2 diabetes, and cardiovascular risk reduction making it the first and only type 2 diabetes medicine approved to reduce the risk of major cardiovascular events in both patients with established heart disease and those with multiple cardiovascular risk factors but no prior cardiac event (primary and secondary prevention)
Learn more at:
"We wanted to create something that feels fun and fresh for summer, while still delivering serious health benefits," said Tracey Halama, CEO of Supergut
Unlike Mounjaro, Farxiga is also FDA approved to protect the kidneys in people with known kidney problems and lower the risk of hospitalization in people with heart failure
Preconception discontinuation timed to each agents half-life is prudent to minimize potential fetal exposure
It is important to clarify that GLP-1 medications do not directly "attack" muscle tissue
